METHODS OF TREATING OCULAR INFLAMMATORY DISEASES

The present invention relates to methods of treating ocular inflammatory diseases by administering ophthalmic pharmaceutical compositions of roflumilast. Administration of ophthalmic pharmaceutical compositions of roflumilast can provide significant immunomodulatory and anti-inflammatory activity re...

Full description

Saved in:
Bibliographic Details
Main Authors JEFFORDS, Elizabeth W, GUKASYAN, Hovhannes John, ESTES, Daniel J, HEMMATI, Houman David, VERHOEVEN, Rozemarijn
Format Patent
LanguageEnglish
French
Published 30.03.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to methods of treating ocular inflammatory diseases by administering ophthalmic pharmaceutical compositions of roflumilast. Administration of ophthalmic pharmaceutical compositions of roflumilast can provide significant immunomodulatory and anti-inflammatory activity relative to existing immunomodulatory, immunosuppressant, or non-steroidal anti-inflammatory therapies, including corticosteroids and antihistamines, while also providing an improved safety and convenience profile relative to one or both agents. La présente invention se rapporte à des méthodes de traitement de maladies inflammatoires oculaires par l'administration de compositions pharmaceutiques ophtalmiques de roflumilast. L'administration de compositions pharmaceutiques ophtalmiques de roflumilast peut fournir une activité immunomodulatrice et anti-inflammatoire considérable par rapport aux thérapies immunomodulatrices, immunosuppressives ou anti-inflammatoires non stéroïdiennes existantes, comprenant des corticostéroïdes et des antihistaminiques, tout en fournissant également un profil de sécurité et de commodité amélioré par rapport à un ou aux deux agents.
Bibliography:Application Number: WO2022US76876